There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.
Amphotericin B (AmB) in small, unilamellar liposomes (AmBisome) has an improved therapeutic
index, and altered pharmacokinetics. The repeat-dose safety and toxicokinetic profiles
of AmBisome were studied at clinically relevant doses.